Tango Therapeutics Inc (NASDAQ: TNGX) is -30.71% lower on its value in year-to-date trading and has touched a low of $5.15 and a high of $13.01 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The TNGX stock was last observed hovering at around $6.55 in the last trading session, with the day’s gains setting it 0.31%.
Currently trading at $6.86, the stock is -8.89% and -24.63% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.15 million and changing 4.73% at the moment leaves the stock -25.61% off its SMA200. TNGX registered -22.49% loss for a year compared to 6-month gain of -6.79%. The firm has a 50-day simple moving average (SMA 50) of $9.1022 and a 200-day simple moving average (SMA200) of $9.22215.
The stock witnessed a -31.40% loss in the last 1 month and extending the period to 3 months gives it a -31.54%, and is -1.72% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.09% over the week and 7.49% over the month.
Tango Therapeutics Inc (TNGX) has around 140 employees, a market worth around $734.98M and $42.51M in sales. Profit margin for the company is -274.04%. Distance from 52-week low is 33.20% and -47.25% from its 52-week high. The company has generated returns on investments over the last 12 months (-41.14%).
with sales reaching $7.81M over the same period.The EPS is expected to shrink by -22.90% this year, but quarterly earnings will post 15.80% year-over-year. Quarterly sales are estimated to shrink -27.20% in year-over-year returns.
Tango Therapeutics Inc (TNGX) Top Institutional Holders
179.0 institutions hold shares in Tango Therapeutics Inc (TNGX), with institutional investors hold 103.82% of the company’s shares. The shares outstanding are 102.20M, and float is at 57.71M with Short Float at 18.74%. Institutions hold 90.40% of the Float.
The top institutional shareholder in the company is TRV GP IV, LLC with over 19.2 million shares valued at $164.75 million. The investor’s holdings represent 17.751% of the TNGX Shares outstanding. As of 2024-06-30, the second largest holder is ECOR1 CAPITAL, LLC with 13.33 million shares valued at $114.38 million to account for 12.3237 of the shares outstanding. The other top investors are FMR LLC which holds 9.41 million shares representing 8.6983% and valued at over $80.73 million, while BOXER CAPITAL, LLC holds 7.5793 of the shares totaling 8.2 million with a market value of $70.34 million.
Tango Therapeutics Inc (TNGX) Insider Activity
The most recent transaction is an insider sale by Third Rock Ventures IV, L.P., the company’s 10% Owner. SEC filings show that Third Rock Ventures IV, L.P. sold 67,400 shares of the company’s common stock on Sep 13 ’24 at a price of $10.53 per share for a total of $0.71 million. Following the sale, the insider now owns 16.86 million shares.
Still, SEC filings show that on Sep 05 ’24, Third Rock Ventures IV, L.P. (10% Owner) disposed off 75,000 shares at an average price of $11.56 for $0.87 million. The insider now directly holds 16,926,475 shares of Tango Therapeutics Inc (TNGX).
